6,247 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Acquired by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 6,247 shares of the company’s stock, valued at approximately $362,000.

Several other large investors have also recently made changes to their positions in the business. GAMMA Investing LLC bought a new position in shares of Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC bought a new position in shares of Astrana Health during the third quarter valued at about $35,000. KBC Group NV purchased a new position in shares of Astrana Health in the third quarter worth about $70,000. Central Pacific Bank Trust Division bought a new stake in shares of Astrana Health in the 3rd quarter valued at about $160,000. Finally, Everence Capital Management Inc. purchased a new stake in Astrana Health during the 3rd quarter valued at about $272,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Trading Up 0.9 %

Shares of ASTH opened at $42.86 on Thursday. Astrana Health, Inc. has a 1-year low of $32.32 and a 1-year high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm’s 50-day moving average price is $53.65 and its 200-day moving average price is $47.98. The firm has a market capitalization of $2.41 billion, a price-to-earnings ratio of 32.66, a PEG ratio of 1.97 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. During the same period in the previous year, the firm posted $0.47 EPS. Sell-side analysts anticipate that Astrana Health, Inc. will post 1.17 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on the company. KeyCorp started coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Truist Financial lifted their target price on shares of Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Robert W. Baird raised their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. BTIG Research upped their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, TD Cowen began coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 target price on the stock. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $65.17.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.